Caroline Palomeque's Stock Ratings

Maxim Group Analyst

Caroline Palomeque is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/09/2025

Overall Average Return

16.2%

Smart Score

60.9%

Overall Average Return Percentile

78th

Number of Ratings

12
Buy NowGet Alert
08/14/2024DAREBuy Now
Dare Bioscience
$2.90
Caroline Palomeque60%
DowngradeBuy → HoldGet Alert
09/07/2023HRMYBuy Now
Harmony Biosciences
$26.57122.05%
Caroline Palomeque60%
→ $59Initiates → BuyGet Alert
09/07/2023KRYSBuy Now
Krystal Biotech
$156.60-1.66%
Caroline Palomeque60%
→ $154Initiates → BuyGet Alert
03/27/2023HALOBuy Now
Halozyme Therapeutics
$56.352.93%
Caroline Palomeque60%
→ $58Reinstates → BuyGet Alert
03/16/2023CEREBuy Now
Cerevel Therapeutics Hldg
Caroline Palomeque60%
→ $22Reinstates → HoldGet Alert
08/30/2022ASNDBuy Now
Ascendis Pharma
$137.1921%
Caroline Palomeque60%
→ $166Assumes → BuyGet Alert
06/23/2022DNLIBuy Now
Denali Therapeutics
$11.02253.9%
Caroline Palomeque60%
→ $39Initiates → BuyGet Alert
06/23/2022RGNXBuy Now
Regenxbio
$5.281054.84%
Caroline Palomeque60%
→ $61Initiates → BuyGet Alert
06/23/2022AVXLBuy Now
Anavex Life Sciences
$7.45436.91%
Caroline Palomeque60%
→ $40Initiates → BuyGet Alert
04/08/2022AGRXBuy Now
Agile Therapeutics
$1.51
Caroline Palomeque60%
DowngradeBuy → HoldGet Alert
11/29/2018AGRXBuy Now
Agile Therapeutics
$1.5198.68%
Caroline Palomeque60%
→ $6000Initiates → BuyGet Alert
08/17/2018DAREBuy Now
Dare Bioscience
$2.903.45%
Caroline Palomeque60%
→ $36Initiates → BuyGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free